113 related articles for article (PubMed ID: 220585)
1. Growth increments with low dose intermittent growth hormone and fluoxymesterone in first year of therapy in hypopituitarism.
Kirkland RT; Clayton GW
Pediatrics; 1979 Mar; 63(3):386-8. PubMed ID: 220585
[TBL] [Abstract][Full Text] [Related]
2. Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy.
Guyda H; Friesen H; Bailey JD; Leboeuf G; Beck JC
Can Med Assoc J; 1975 Jun; 112(11):1301-9. PubMed ID: 165002
[TBL] [Abstract][Full Text] [Related]
3. Low dose single weekly injections of growth hormone: response during first year of therapy of hypopituitarism.
Rosenbloom AL; Riley WJ; Silverstein JH; Garnica AD; Netzloff ML; Weber FT
Pediatrics; 1980 Aug; 66(2):272-6. PubMed ID: 7402812
[TBL] [Abstract][Full Text] [Related]
4. Growth and growth hormone therapy in children with achondroplasia: a two-year experience.
Stamoyannou L; Karachaliou F; Neou P; Papataxiarchou K; Pistevos G; Bartsocas CS
Am J Med Genet; 1997 Oct; 72(1):71-6. PubMed ID: 9295079
[TBL] [Abstract][Full Text] [Related]
5. Treatment of hypopituitarism with recombinant somatropin for 1 year.
Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
Acta Paediatr Scand Suppl; 1988; 347():169-75. PubMed ID: 3254031
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment for short stature.
Van Vliet G; Styne DM; Kaplan SL; Grumbach MM
N Engl J Med; 1983 Oct; 309(17):1016-22. PubMed ID: 6684729
[TBL] [Abstract][Full Text] [Related]
7. The correlation of the IGF-I, IGFBP-3, and ALS generation test to height velocity after 6 months of recombinant growth hormone therapy in girls with Turner syndrome.
Collett-Solberg PF; Pessoa de Queiroz AN; Cardoso ME; Jusan RC; Vaisman M; Guimarães MM
Growth Horm IGF Res; 2006 Aug; 16(4):240-6. PubMed ID: 16908209
[TBL] [Abstract][Full Text] [Related]
8. [Results of treatment with human growth hormone in children with pituitary insufficiency under 7 years of age. Study of 26 cases].
Mugnier E; Ployard F; Roy MP; Fermanian J; Rappaport R
Arch Fr Pediatr; 1985 Oct; 42(8):671-6. PubMed ID: 4074096
[TBL] [Abstract][Full Text] [Related]
9. Results of four years of intermittent human growth hormone (hGH) and fluoxymesterone therapy in hypopituitary dwarfism.
Kirkland RT; Harrist RB; Clayton GW
Pediatrics; 1980 Mar; 65(3):562-6. PubMed ID: 7360545
[No Abstract] [Full Text] [Related]
10. Recombinant human growth hormone in short children born small for gestational age. German Study Group.
Butenandt O; Lang G
J Pediatr Endocrinol Metab; 1997; 10(3):275-82. PubMed ID: 9388818
[TBL] [Abstract][Full Text] [Related]
11. [Delay of constitutional development--studies on therapy with growth hormone].
Butenandt O
Klin Padiatr; 1984; 196(2):69-72. PubMed ID: 6737950
[TBL] [Abstract][Full Text] [Related]
12. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma.
Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A
Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937
[TBL] [Abstract][Full Text] [Related]
14. [Retrospective comprehensive assessment of the treatment effect of children with growth hormone deficiency].
Kostecka L; Wasikowa R
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):161-9. PubMed ID: 16232369
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship in the treatment of hypopituitary children with human growth hormone: a retrospective survey.
Job JC; Chaussain JL; Garnier P; Rolland A; Joab N
Acta Paediatr Scand Suppl; 1987; 337():93-105. PubMed ID: 3481186
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
[TBL] [Abstract][Full Text] [Related]
17. The response to treatment with pituitary growth hormone: the New Zealand experience.
Livesey JH; Cuneo RC; Donald RA; Harris RG; Ibberston HK; Costello JM; Holdaway IM; Gluckman PD; Fraser TR; Chapman GE
N Z Med J; 1989 Aug; 102(873):399-402. PubMed ID: 2761875
[TBL] [Abstract][Full Text] [Related]
18. [Results of treatment with growth hormone. Apropos of 31 cases of pituitary insufficiency].
Sablayrolles B; Sanz MT; Mas B; Dutau G; Rochiccioli P
Sem Hop; 1984 Jan; 60(2):106-11. PubMed ID: 6322324
[TBL] [Abstract][Full Text] [Related]
19. Enhanced linear growth responses in hypopituitary dwarfs treated with growth hormone plus androgen versus growth hormone alone.
MacGillivray MH; Kolotkin M; Munschauer RW
Pediatr Res; 1974 Feb; 8(2):103-8. PubMed ID: 4810507
[No Abstract] [Full Text] [Related]
20. Comparison of dose frequency of human growth hormone in treatment of organic and idiopathic hypopituitarism.
Moore WV; Kaplan S; Raiti S
J Pediatr; 1987 Jan; 110(1):144-8. PubMed ID: 3794876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
